Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Platelet Derived Growth Factor BB (PDGFBB) ELISA Kit-Sandwich

Cat. No.EK12F965

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Canine Platelet Derived Growth Factor BB (PDGFBB) ELISA Kit-Sandwich is designed for the quantitative determination of Canine Platelet Derived Growth Factor BB (PDGFBB) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Canine PDGFBB.
Target Species Canine
Species Reactivity Canine
Detection Range 31.25-2000 pg/mL
Sensitivity 12.8 pg/mL
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%
Assay Time Around 210 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids.

Target Information

PDGF acts as a potent mitogen for cells of mesenchymal origin, including fibroblasts, smooth muscle cells, and glial cells. PDGF-BB is a protein that stimulates mesenchymal stem cells and enhances angiogenesis and osteogenesis in a dose-dependent manner. Recent research has shown that co-overexpression of PDGF-BB and IL-4 could be a promising strategy to improve bone regeneration based on mesenchymal stem cells.

Target/Biomarker Canine PDGFBB
Target Synonym PDGF-BB

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Zhang, N. et al. PDGF-BB and IL-4 co-overexpression is a potential strategy to enhance mesenchymal stem cell-based bone regeneration. Stem cell research & therapy. 2021, 12: 40.
Inquiry Basket